Integration of proteomics and metabolomics reveals promotion of proliferation by exposure of bisphenol S in human breast epithelial MCF-10A cells.

PMID:  Sci Total Environ. 2020 Jan 7 ;712:136453. Epub 2020 Jan 7. PMID: 31945527 Abstract Title:  Integration of proteomics and metabolomics reveals promotion of proliferation by exposure of bisphenol S in human breast epithelial MCF-10A cells. Abstract:  Bisphenol S (BPS) has been reported to have similar estrogenic effects as bisphenol A (BPA). Considering the endocrine …

Exposure to proton pump inhibitors and risk of pancreatic cancer.

PMID:  Expert Opin Drug Saf. 2020 Jan 11. Epub 2020 Jan 11. PMID: 31928106 Abstract Title:  Exposure to proton pump inhibitors and risk of pancreatic cancer: a meta-analysis. Abstract:  : To estimate the pooled pancreatic cancer risk among subjects exposed versus not exposed to proton pump inhibitors.: The authors searched PubMed, EMBASE, Scopus, Cochrane Library, …

The use of proton pump inhibitors may increase symptoms of muscle function loss in patients with chronic illnesses.

PMID:  Int J Mol Sci. 2020 Jan 3 ;21(1). Epub 2020 Jan 3. PMID: 31947724 Abstract Title:  The Use of Proton Pump Inhibitors May Increase Symptoms of Muscle Function Loss in Patients with Chronic Illnesses. Abstract:  Long-term use of proton pump inhibitors (PPIs) is common in patients with muscle wasting-related chronic diseases. We explored the …

Lactobacillus reuteri improves gut barrier function and affects diurnal variation of the gut microbiota in mice fed a high-fat diet.

PMID:  Food Funct. 2019 Aug 1 ;10(8):4705-4715. Epub 2019 Jul 15. PMID: 31304501 Abstract Title:  Lactobacillus reuteri improves gut barrier function and affects diurnal variation of the gut microbiota in mice fed a high-fat diet. Abstract:  Lactobacillus reuteri FN041 is a secretory IgA-targeted Lactobacillus strain from human breast milk that has probiotic potential. The aim …

Lactobacillus reuteri V3401 reduces inflammatory biomarkers and modifies the gastrointestinal microbiome in adults with metabolic syndrome.

PMID:  Nutrients. 2019 Jul 31 ;11(8). Epub 2019 Jul 31. PMID: 31370223 Abstract Title:  V3401 Reduces Inflammatory Biomarkers and Modifies the Gastrointestinal Microbiome in Adults with Metabolic Syndrome: The PROSIR Study. Abstract:  : Previous studies have reported that probiotics may improve clinical and inflammatory parameters in patients with obesity and metabolic syndrome (MetS).V3401 has shown …

Lactobacillus reuteri extracts promoted wound healing via PI3K/AKT/β-catenin/TGFβ1 pathway

PMID:  Stem Cell Res Ther. 2019 Aug 7 ;10(1):243. Epub 2019 Aug 7. PMID: 31391121 Abstract Title:  Lactobacillus reuteri extracts promoted wound healing via PI3K/AKT/β-catenin/TGFβ1 pathway. Abstract:  BACKGROUND: The balance of oral microbiomes is crucial to maintain oral health. Microecological imbalance can impair the function of mesenchymal stem cells (MSCs) and lead to delay wound …

The application of Lactobacillus reuteri CCM 8617 and flaxseed positively improved the health of mice challenged with enterotoxigenic E. coli O149:F4.

PMID:  Probiotics Antimicrob Proteins. 2019 Aug 13. Epub 2019 Aug 13. PMID: 31410766 Abstract Title:  The Application of Lactobacillus reuteri CCM 8617 and Flaxseed Positively Improved the Health of Mice Challenged with Enterotoxigenic E. coli O149:F4. Abstract:  The aim of our study was to monitor the effects of dietary synbiotics on experimentally infected mice. Sixty …

Lactobacillus reuteri protects mice against Salmonella typhimurium challenge by activating macrophages to produce nitric oxide.

PMID:  Microb Pathog. 2019 Dec ;137:103754. Epub 2019 Sep 17. PMID: 31539587 Abstract Title:  Lactobacillus reuteri protects mice against Salmonella typhimurium challenge by activating macrophages to produce nitric oxide. Abstract:  Lactobacillus reuteri, a typical intestinal symbiotic bacterium, plays an important role in maintaining intestinal flora stability and host health. However, the effect of Lactobacillus reuteri …

Systematic seview with meta-analysis: Lactobacillus reuteri DSM 17938 for treating acute gastroenteritis in children.

PMID:  Nutrients. 2019 Nov 14 ;11(11). Epub 2019 Nov 14. PMID: 31739457 Abstract Title:  Systematic Review with Meta-Analysis:DSM 17938 for Treating Acute Gastroenteritis in Children. An Update. Abstract:  The effectiveness ofDSM 17938 () for the management of acute gastroenteritis (AGE) has been recently questioned. We performed a systematic review to update evidence onfor treating AGE …

L. reuteri is a good alternative for patients with chronic dyspepsia for the eradication of H. pylori infection.

PMID:  Med Pharm Rep. 2019 Oct ;92(4):352-355. Epub 2019 Oct 25. PMID: 31750434 Abstract Title:  versus triple therapy for the eradication ofin functional dyspepsia. Abstract:  Background and aim: The eradication ofinfection using PPI associated with different combinations of two or three antibiotics entails high risks of side effects and non- adherence. Therefore probiotics have been …

Design a site like this with WordPress.com
Get started